Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
2005
Breast cancer
2016 Standout
Carcinoma of the breast in males
1998
Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer
1990
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†
2002
Stages at presentation, prognostic factors, and outcome of breast cancer in males
1999
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Longitudinal risk-based health care for adult survivors of childhood cancer
2003
Sentinel lymph node biopsy in male breast cancer patients
2004
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Breast carcinoma in men
2004 Standout
Cancer of the male breast
2000
Clinical relevance of biologic factors in male breast cancer
2001
Molecular markers in male breast carcinoma
1998
Male breast carcinoma
1999
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
2006
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Tamoxifen in the Treatment of Breast Cancer
1988
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer
1993
Male breast cancer
2006 Standout
Synchronous bilateral noninvasive ductal carcinoma of the male breast: A case report
2003
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Survival analysis in natural history studies of disease
1989
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Understanding and management of male breast cancer: a critical review
2007
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
2009
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Male breast cancer: is the scenario changing
2008
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
2005
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
2006
Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death
1994 Standout
Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution
2010
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Ductal carcinoma in situ (DCIS) in the male breast
1998
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT
2002
Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study
2005
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer
2010
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Cutaneous Adverse Effects With HER1/EGFR-Targeted Agents: Is There a Silver Lining?
2005
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
1998 Standout
An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients
1999
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Racial Disparities in Treatment and Survival of Male Breast Cancer
2007
External Beam Radiotherapy in the Treatment of Male Breast Carcinoma: Patterns of Failure in a Single Institute Experience
2005
Breast Cancer Treatment
2019 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
1999
Prognostic Variables in Male Breast Cancer
2000
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Strategies in treating male breast cancer
2007
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
How to treat male breast cancer
2007
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Prognostic Factors for Carcinoma of the Male Breast
1995
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Post-mastectomy radiation in male breast cancer
2002
Breast Cancer in Men
2002 Standout
BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
2003
Works of Y Graïc being referenced
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases
2001
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
1993
Male breast cancer: Results of the treatments and prognostic factors in 397 cases
1995
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis
1987
CA-15.3: Prognostic factor in breast cancer
1998
Ductal carcinoma in situ of the male breast. Analysis of 31 cases
1997
Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial
1986
[Breast cancer in males: a study of 15 cases of pure ductal carcinoma in situ].
1992
Phase III trial comparing doxorubicin docetaxel (AT) with doxorubicin cyclophosphamide (AC) in the adjuvant treatment of high-risk node negative (pN0) and limited node positive (pN+≤3) breast cancer (BC) patients (pts): First analysis of toxicity
2004
Sequential or simultaneous chemo-radiotherapy in operable breast cancer. A French multicentric phase III study — State of inclusions
1998